Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2010 TO 2019]"
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
PubPharm (4.792)
1
This study is being done to test the effectiveness and safety of an investigational drug called acalabrutinib (ACP-196) when taken with already marketed drugs called Venetoclax and Obinutzumab in comparison to chemotherapy that is already in wide use for treatment of patients who have chronic lymphocytic leukemia and who have never been treated before. : A Randomized, Multicenter, Open-Label, Phase 3 Study to Compare the Efficacy and Safety of Acalabrutinib (ACP-196) in Combination with Venetoclax with and without Obinutuzumab Compared to Investigator’s Choice of Chemoimmunotherapy in Subjects with Previously Untreated Chronic Lymphocytic Leukemia Without del(17p) or TP53 Mutation - Not available at this time
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
2
A Clinical Study Comparing Rituximab and Cladribine for Relapsing Multiple Sclerosis : Norwegian study of Oral cladribine versus Rituximab in Multiple Sclerosis (NOR-MS). A prospective randomized open-label blinded endpoint (PROBE) multicenter non-inferiority study. - NOR-MS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
3
A study comparing current standard therapies with fedratinib for the treatment of myelofibrosis (either diagnosed alone or after polycythemia vera or essential thrombocytopenia) in subjects who have previously received ruxolitinib : A Phase 3, multicenter, open-label, randomized study to evaluate the efficacy and safety of fedratinib compared to best available therapy in subjects with DIPSS - intermediate or high-risk primary myelofibrosis, post-polycythemia vera myelofibrosis, or post-essential thrombocythemia myelofibrosis and previously treated with ruxolitinib - The Freedom 2 trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
4
Research into effectiveness and costs concerning the use of (vaginally administered) oestrogen before and after vaginal prolapse surgery, in women after menopause. : Cost-effectiveness of perioperative vaginally administered oestrogen in postmenopausal women undergoing prolapse surgery. - EVA trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
5
Transplant Antibody-mediated Rejection: Guiding Effective Treatments-1 (TAR:GET-1) : A multicentre randomised controlled trial to assess the safety and efficacy of adding rituximab to standard of care in treating acute antibody-mediated rejection in kidney transplantation (Transplant Antibody-mediated Rejection: Guiding Effective Treatments-1 (TAR:GET-1)) - TAR:GET-1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
6
A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy : A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
7
A phase 3 study to Evaluate the Efficacy and Safety of Pimavanserin for the Treatment of Schizophrenia : A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (Enhance-2) - Enhance-2
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
8
Study to investigate a short course radiation therapy followed by prolonged pre-operative chemotherapy and surgery compared to standard chemoradiotherapy and surgery in in rectal cancer : Randomized Multicentre Phase III study of short course radiation therapy followed by prolonged pre-operative chemotherapy and surgery in primary high risk rectal cancer compared to standard chemoradiotherapy and surgery and optional adjuvant chemotherapy - RAPIDO
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
9
A study investigating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin's lymphoma. : A Phase III, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin’s lymphoma (iNHL) - CHRONOS-3 - Copanlisib and rituximab in relapsed iNHL
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
10
Long-Term Tolerability and Safety of HYQVIA/HyQviain CIPD : Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[480]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2010-2019
Filter aufheben
Thema: Phase: Phase 3
Medienart
4.792
Aufsätze
4.792
E-Artikel
4.792
E-Ressourcen
Zeitschriftentitel
4.792
WHO International Clinical Trials Registry Plat...
Thema
4.792
610
Phase: Phase 3
4.792
Recruitment Status: Authorised-recruitment may ...
4.792
Study Type: Interventional
26
Medical Condition: Moderately to Severely Activ...
16
Medical Condition: Ulcerative colitis MedDRA ve...
14
Medical Condition: Moderately to Severely Activ...
14
Medical Condition: Non-Small Cell Lung Cancer;T...
14
Medical Condition: Ulcerative colitis MedDRA ve...
12
Medical Condition: Moderately to Severely Activ...
12
Medical Condition: Trigeminal Neuralgia MedDRA ...
12
Medical Condition: Untreated unresectable Pleur...
10
Medical Condition: AL Amyloidosis (Newly Diagno...
10
Medical Condition: Acute Myeloid Leukemia MedDR...
10
Medical Condition: First Line Non-Small Cell Lu...
10
Medical Condition: Hepatocellular Carcinoma Med...
10
Medical Condition: High Risk Neuroblastoma;Ther...
10
Medical Condition: Stage IV or Recurrent Non-Sm...
8
Medical Condition: ACUTE MYELOID LEUKEMIA MedDR...
8
Medical Condition: Atopic Dermatitis MedDRA ver...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2010-2019
2.410
2019
1.210
2018
774
2017
398
2016
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
4.664
Englisch
86
Unbestimmt
28
Französisch
4
Dänisch
4
Italienisch
4
Schwedisch
2
Deutsch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...